2000
DOI: 10.1046/j.1365-2168.2000.01534.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of surgical subspecialization on breast cancer outcome

Abstract: There was a significant improvement in outcome for patients with breast cancer after surgical subspecialization in Bedford. This may relate to the more frequent use of appropriate systemic therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
24
0
2

Year Published

2003
2003
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 15 publications
1
24
0
2
Order By: Relevance
“…They analyzed patients between 1990-1992 and 1993-1996 before and after the advent of surgical subspecialization. After specialization, the disease-free survival improved from 70 to 79 %, and recurrence rates fell from 22 to 12 % at 3 years [17]. Similar results have been demonstrated before [18].…”
Section: Breast Cancer Outcomessupporting
confidence: 87%
“…They analyzed patients between 1990-1992 and 1993-1996 before and after the advent of surgical subspecialization. After specialization, the disease-free survival improved from 70 to 79 %, and recurrence rates fell from 22 to 12 % at 3 years [17]. Similar results have been demonstrated before [18].…”
Section: Breast Cancer Outcomessupporting
confidence: 87%
“…So konnten auch Golledge et al [16] eine Verbesserung der Überle-bensraten nach Einführung einer operativen Subspezialisierung für Mammakarzinomoperateure 1993 in Bedford, England nachweisen. Insgesamt wurden vor der Spezialisierung die Frauen von Ärzten gesehen, die 10-38 neue Fälle pro Jahr behandelten, danach wurde die Diagnostik und Therapie nur noch von Ärzten durchgeführt, die 65 bis 75 neue Mammakarzinompatientinnen pro Jahr sahen.…”
Section: Rolle Der Spezialisierung Des Operateursunclassified
“…Chemotherapy and hormone therapy have been repeatedly demonstrated to reduce the risk of local recurrence (EBCTCG, 1992) and improve survival in appropriate patients (EBCTCG, 1998;Aapro, 2001), although the overall use of chemotherapy during the study period was low. The information on local recurrence was not available in this study but there is evidence that specialisation reduces the risk of local recurrence due to increased use of systemic therapy (Golledge et al, 2000). The negative impact of chemotherapy in the multivariate analysis was most likely to have been due to the selection of the poorest prognosis individual patients for this treatment during the period in question.…”
mentioning
confidence: 75%